Search

Author/Creator Lejeune, Pascale

1. Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models. Issue 5 (23rd March 2019)

Authors:
Sugawara, Tatsuo; Baumgart, Simon J.; Nevedomskaya, Ekaterina; Reichert, Kristin; Steuber, Holger; Lejeune, Pascale; Mumberg, Dominik; Haendler, Bernard
Journal:
International journal of cancer
Issue:
Volume 145:Issue 5(2019)
Page Start:
1382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma. (27th June 2017)

Authors:
Bernasconi, Elena; Gaudio, Eugenio; Lejeune, Pascale; Tarantelli, Chiara; Cascione, Luciano; Kwee, Ivo; Spriano, Filippo; Rinaldi, Andrea; Mensah, Afua A.; Chung, Elaine; Stathis, Anastasios; Siegel, Stephan; Schmees, Norbert; Ocker, Matthias; Zucca, Emanuele; Haendler, Bernard; Bertoni, Francesco
Journal:
British journal of haematology
Issue:
Volume 178:Number 6(2017)
Page Start:
936
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. (October 2018)

Authors:
Zanconato, Francesca; Battilana, Giusy; Forcato, Mattia; Filippi, Letizia; Azzolin, Luca; Manfrin, Andrea; Quaranta, Erika; Di Biagio, Daniele; Sigismondo, Gianluca; Guzzardo, Vincenza; Lejeune, Pascale; Haendler, Bernard; Krijgsveld, Jeroen; Fassan, Matteo; Bicciato, Silvio; Cordenonsi, Michelan...
Journal:
Nature medicine
Issue:
Volume 24:Number 10(2018)
Page Start:
1599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗